Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL

Imprimis NJOF, LLC has recalled Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on January 14, 2026 and was initiated on December 18, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, with approximately 596 boxes of 11,920 pre-filled syringes affected. The company behind the recall is Imprimis NJOF, LLC, based in Ledgewood, NJ. The FDA describes the product as: “Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.”

Why was Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL recalled?

According to the FDA, the stated reason for the recall is: “Presence of particulate matter - Glass like particles.” In plain terms, this recall relates to foreign material.

A foreign material recall means that pieces of something which should not be in food — such as metal, plastic, or glass — may be present. These can pose a choking hazard or cause injury. Recalls like these are issued to remove the affected product before anyone is hurt.

What should you do?

If you think you may have bought Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, compare it against the product description and identifying codes (Lot: 25APR001A, 25APR001B, Expires: 04/03/2026.) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Imprimis NJOF, LLC or your local health authority.

About this recall

This recall was distributed in NJ. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.